20 Overview of A Gamma Validation
20 Overview of A Gamma Validation
20 Overview of A Gamma Validation
7. Dose Range Determination During routine irradiation the product volume and density will increase as it is processed in a larger carrier or tote, thus a dose window or range needs to be established for a large irradiator to process product efficiently. The chosen Sterilization Dose range will be the minimum dose needed to achieve the sterility claim and a dose level value below the dose applied during the Material Test as the maximum end of the range, or generally a minimum of at least 1.6 times the Sterilization Dose. A dose level value below the dose applied during the Material Test is recommended as the maximum end of the range, or generally a minimum of at least 1.6-2.0 times the Sterilization Dose. 8. Routine Processing Facility Determination Once the Sterilization Dose Range is established a STERIS Isomedix Services account manager will determine the best Processing Facility to routinely process marketable product and introduce the manufacturer to the facility.2 9. Routine Sterilization Customer Set-Up The processing facility will ask that Processing Specifications and new Customer set-up documentation are completed to provide the means to identify all incoming products and the required dose range to achieve the sterility claim. 10. Dose Mapping and Routine Dosimeter Placement Determination Once the product is received by the processing facility, measurements of the product carton and density will be made. The facility will establish if like product density and volume has been processed and will perform a Dose Mapping on the product, if required. Dose mapping is performed by determining the most efficient means of placing product in a carrier or tote and placing numerous dosimeters throughout the product load to establish the minimum and maximum areas of imparted dose. Once these areas have been determined, routine dosimeter placement will be limited to the minimum and maximum dose zones in a select sampling of routine processing totes or carriers.
11. Routine Processing Once the processing specifications are established, routine processing irradiations will be identified by the product code, as received at the facility, and the irradiation process will commence without further requirements from the Customer. Although it is recommended that if any product changes (size or density), or priority turn time requirements occur; the Customer contact the processing facility for communicating the unique requirements. 12. Dose Audits As the initial sterilization dose determination was based on the natural bioburden of the product and packaging, the ANSI/AAMI/ ISO 11137 standard recognizes that the microbial population (quantity or type) can change with seasonal or periodic manufacturing changes, thus the standard requires a bioburden determination and Dose Audit at the Verification Dose level to confirm that the minimum sterilization dose is still valid. These irradiations would be performed at the research irradiator at the same tight constraints of the verification dose (+/- 10%) in addition to performing a Sterility Test to validate effectiveness.3
References 1. See STERIS Isomedix Technical Tips #02, #04, and #09 at www.Isomedix.com for more information 2. Consult the STERIS Isomedix Sales staff at 877.783.7479 for assistance 3. See ANSI/AAMI/ISO 11137-2006 or 11737 for more information 4. Consult the STERIS Isomedix Services Radiation TechTeam at 847.247.4782 for assistance
For more information, please contact: STERIS Isomedix Services, Inc. 5960 Heisley Road Mentor, Ohio 44060 877.783.7479 www.isomedix.com
TechTip 20: 11/10, Rev 1